Intent to Award Sole Source Contract - ID/IQ areawide Siemens Healthcare Diagnostic Inc - RapidPoint 500e®Arterial Blood Gas (ABG) Analyzers, Reagents, Controls, Consumables, Service & Support for IHS Great Plains Area (GPA) hospitals & healthcare clinics
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Great Plains Area Indian Health Service (GPAIHS) intends to award a sole source, firm fixed-price, area-wide Indefinite Delivery, Indefinite Quantity (ID/IQ) contract to Siemens Healthcare Diagnostic, Inc. This contract is for RapidPoint 500e® Arterial Blood Gas (ABG) Analyzers, Reagents, Controls, Consumables, Service & Support, aiming to support all GPA IHS hospitals and clinics. Responses demonstrating competitive advantage are due by February 19, 2026.
Scope of Work
This ID/IQ will cover the procurement of RapidPoint 500e® Arterial Blood Gas (ABG) Analyzers, along with their proprietary reagents, controls, and consumables. It also includes establishing a comprehensive service and support agreement for these systems across all Great Plains Area Indian Health Service hospitals and healthcare clinics.
Contract & Timeline
- Type: Intent to Award Sole Source (Firm Fixed-Price ID/IQ)
- Awardee: Siemens Healthcare Diagnostic, Inc. (Large Business)
- Justification: Siemens is identified as the sole manufacturer and authorized service provider for RapidPoint 500e® ABG Analyzers and their proprietary supplies, aligning with FAR 6.302-1. Previous market research (sources sought) did not yield any responsible competitive responses.
- Duration: Ordering period not exceeding five (5) years or sixty (60) months.
- Anticipated Award Date: March 15, 2025.
- Estimated Value: Above the simplified acquisition threshold.
- Response Due: February 19, 2026, 6:00 PM EST.
- Published: February 4, 2026.
Evaluation
Responses to this Notice of Intent must provide clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive, and would not hinder the agency's mission objective. The Government retains sole discretion on whether to pursue a competitive procurement.
Additional Notes
This is a Notice of Intent and not a request for quotes or proposals. The Government will not be responsible for any costs incurred in responding. Questions or comments should be directed via email to Ursula Maslonka (Ursula.Maslonka@ihs.gov). The email subject line must include: "Notice of Intent IHS1519445-IHS1512343, Siemens Healthcare Diagnostic, Inc."